Document Detail


Early use of inhaled corticosteroids in infancy.
MedLine Citation:
PMID:  16263466     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The inability to accurately predict the outcome of infants with recurrent wheezy bronchitis makes the early use of inhaled corticosteroids (ICS) controversial. Data from bronchoalveolar lavages and epidemiological surveys suggest a persistent inflammation of the airways in the more severe cases. Prospective studies, mostly with nebulized corticosteroids, have demonstrated clinical efficacy on daytime and nightime symptoms, reduced requirements for rescue bronchodilators and a real steroid sparing effect. In infants with episodic viral-associated wheeze with or without interval symptoms, ICS use carries the risk of overtreatment and of adverse effects. Long-term prospective studies are urgently required to assess the efficacy and safety of ICS and their possible effects on the natural history of infantile asthma.
Authors:
J Blic; P Scheinmann
Related Documents :
2286996 - Helminth and arthropod parasites of angora goats on irrigated kikuyu grass pastures in ...
25374396 - Effect of single embryo transfer on the risk of preterm birth associated with in vitro ...
6595566 - Death from asthma in auckland: circumstances and validation of causes.
25217156 - Erratum.
16138226 - Umbilical cord blood and neonatal endothelin-1 levels in preterm newborns with and with...
19485816 - Fetal exposure to oral pathogens and subsequent risk for neonatal intensive care admiss...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Paediatric respiratory reviews     Volume:  1     ISSN:  1526-0542     ISO Abbreviation:  Paediatr Respir Rev     Publication Date:  2000 Dec 
Date Detail:
Created Date:  2005-11-02     Completed Date:  2005-12-13     Revised Date:  2009-10-14    
Medline Journal Info:
Nlm Unique ID:  100898941     Medline TA:  Paediatr Respir Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  368-71     Citation Subset:  IM    
Affiliation:
Hôpital des Enfants Malades, 149 rue de Sèvres, Paris, 75015, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Adrenal Cortex Hormones / administration & dosage*
Age Factors
Asthma / drug therapy
Bronchitis / complications,  drug therapy
Bronchopulmonary Dysplasia / drug therapy
Drug Administration Schedule
Humans
Infant
Infant, Newborn
Respiratory Sounds / etiology
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pulmonary hypertensive diseases.
Next Document:  Acute lung injury: cellular mechanisms and derangements.